Lipocine Inc.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 5, 2024
8-K Jun 3, 2024
DEFA14A Jun 3, 2024
10-Q May 9, 2024
8-K May 9, 2024
8-K May 8, 2024
8-K May 1, 2024
8-K Apr 29, 2024
8-K Apr 26, 2024
424B5 Apr 26, 2024
EFFECT Apr 25, 2024
CORRESP Apr 24, 2024
S-3/A Apr 23, 2024
DEF 14A Apr 23, 2024
8-K Apr 11, 2024
8-K Mar 28, 2024
8-K Mar 25, 2024
4 Mar 12, 2024
4 Mar 12, 2024
8-K Mar 7, 2024
8-K Mar 7, 2024
10-K Mar 7, 2024
8-K Mar 6, 2024
8-K Feb 12, 2024
8-K Jan 18, 2024
← Newer Page 6 of 33 · 820 filings Older →